FFAR1; FFAR4; | |
FAAH; TERT; HPGD; CBR1; AKR1B1; HSD17B10; ALOX15; | |
CDK6; | |
CA2; CA12; CA1; CA9; CA7; CA4; | |
PPARA; PPARD; PPARG; | |
HIF1A; TP53; | |
ABCG2; | |
LMNA; NPC1; FABP3; FABP5; MAPT; | |
XDH; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
ATP-binding cassette | ABCG2 | ATP-binding cassette sub-family G member 2 | Q9UNQ0 | CHEMBL5393 |
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 family 19 | CYP19A1 | Cytochrome P450 19A1 | P11511 | CHEMBL1978 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | FAAH | Anandamide amidohydrolase | O00519 | CHEMBL2243 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 3.629E-12 | 5.645E-09 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.220E-11 | 4.375E-08 | CA1, CA12, CA2, CA4, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.351E-10 | 1.279E-07 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.514E-10 | 1.373E-07 | CA1, CA12, CA2, CA4, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 2.889E-10 | 2.330E-07 | CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2C9 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 4.424E-09 | 2.240E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0009725; response to hormone | 1.717E-07 | 6.030E-05 | AKR1B1, CA2, CA9, CYP1A2, FABP3, FFAR4, HPGD, NPC1, PPARA, PPARG |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 1.172E-06 | 3.073E-04 | HIF1A, LMNA, PPARD, TERT, TP53 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.186E-06 | 3.073E-04 | CYP1A2, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0034754; cellular hormone metabolic process | 1.414E-06 | 3.622E-04 | AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 5.223E-08 | 8.670E-07 | CYP1A2; CYP1A1; CYP1B1; CYP3A4; CYP19A1 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.965E-05 | 2.237E-04 | CYP1A2; XDH |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 4.640E-05 | 3.209E-04 | CYP1A2; CYP1A1; CYP1B1 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 4.078E-06 | 4.767E-05 | CYP2C9; CBR1; ALOX15; CYP2C19 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.404E-09 | 3.883E-08 | CYP2C9; CYP1A2; ALOX15; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 4.931E-06 | 4.767E-05 | CYP2C9; CYP1A2; CYP1A1; CYP3A4 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.231E-13 | 1.852E-11 | CA12; CA1; CA2; CA4; CA7; CA9 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.862E-09 | 5.938E-08 | CYP2C9; CBR1; CYP1A2; CYP1A1; CYP1B1; CYP3A4 |
hsa00982 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 6.266E-06 | 5.200E-05 | CYP2C9; CYP1A2; CYP3A4; CYP2C19 |
hsa00983 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.934E-03 | 1.282E-02 | CYP3A4; XDH |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
C00-D49: Neoplasms | Prostate cancer | C61 | TERT |
C00-D49: Neoplasms | Pancreatic cancer | C25 | TERT |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Bladder cancer | C67 | CYP19A1 |
C00-D49: Neoplasms | Ovarian cancer | C56 | TERT |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A; CA9 |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | FAAH |
C00-D49: Neoplasms | Hormonally-responsive breast cancer | C50 | CYP19A1 |